Terms and Conditions

1. Terms of Use The website and its materials are intended exclusively for informational and B2B purposes (tailored for investors, researchers, oncologists, and pharmaceutical companies). Accessing and using the site constitutes full acceptance of these terms.

2. Strict Medical Disclaimer EndoVia Therapeutics develops a predictive systems pharmacology platform and digital twins for personalized oncology.

• The information provided on this website does not constitute medical advice, diagnosis, prescription, or direct treatment recommendations for patients.

• The described technology serves as a decision-support tool for qualified medical professionals. Patients must not use the website for self-experimentation or self-treatment.

3. Intellectual Property All textual and visual content, algorithm descriptions, digital twin methodologies, and platform designs are the exclusive property of EndoVia Therapeutics. Core platform technologies are protected by licensed intellectual property, including international patent application WO2024003373A1. Any unauthorized copying, data parsing, or reverse-engineering is strictly prohibited.

4. Limitation of Liability

EndoVia Therapeutics shall not be held liable for any direct, indirect, or reputational damages arising from the use of information provided on this public website. All public data is provided on an "As Is" basis.

5. Governing Law and Jurisdiction These terms are governed by the laws of the Republic of Slovenia. Any legal disputes shall be subject to the exclusive jurisdiction of the competent courts in Maribor, Slovenia